NCT02695446View on ClinicalTrials.gov

Administration of Oral Extended Release Minocycline for Assessment of Skin and Plasma Concentrations of Minocycline

PHASE4CompletedINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

April 30, 2016

Study Completion Date

May 31, 2016

Conditions

Acne

Interventions

DRUG

Minocycline

Oral extended release minocycline

Trial Locations (1)

19008

KGL Skin Study Center, Broomall

Sponsors

Lead Sponsor

BioPharmX, Inc.

All Listed Sponsors

lead

BioPharmX, Inc.

INDUSTRY